Hey
There was a little selling pressure this week as the markets took a dive. But the trade is still in positive territory. The stock would have to fall 8% from its current price to get to even on the trade.
There is a conference that that the company is participating in next week. So there could be some movement based on news.
Earnings are normally around this time in the quarter.
- Opinions are given on this blog. Before investing, please consult a financial professional. This blog takes no responsibility for any losses occurred from trades that use its material as a basis for the trade.
- The account does not fully divulge all information on companies that have open trades. This is to protect current trade. When the trade on a particular stock ends, the account will give out the rest of the details (stock name, price purchased, call purchased, news on company/ETF, chart info, etc.) Please feel free to ask questions and the account will answer them the best way possible can without endangering the trade. If you have any info regarding call selling, be sure to comment or send an email.
Saturday, February 6, 2010
Friday, January 29, 2010
New Capital...7 weeks left
Hey
New Capital has been added to the account.
There are seven weeks left on the current trade. The stock has not moved this week. There has been no news this week.
New Capital has been added to the account.
There are seven weeks left on the current trade. The stock has not moved this week. There has been no news this week.
Wednesday, January 27, 2010
call selling research results 1/27
Hey
In doing research for the next trade, the account showed the following results for the Feb options:
1) Eastman Kodak currently has a price of about $4.60 today. The Feb $5.00 option is currently bidding for $0.20.
2)JA Solar currently has a price of about $4.76 today. The Feb option is currently bidding for $0.35
3) TGB is currently trading at about $4.75 today. The Feb $5.00 is currently bidding at $0.15
The Account does not have a position in any of these stocks and has not traded these stocks in the past.
- This information is not to be used as a recommendation to buy or sell. It is simply information (and sometimes opinions) given for the reader of this blog. Before investing, please consult a financial professional. This blog takes no responsibility for any losses or gains occurred from trades that use its material.
- The account does not fully divulge all information on open trades. This is for protection of the trade. When the trade on a particular stock ends, the account will give out the rest of the details (stock name, price purchased, call purchased, news on company/ETF, chart info, etc.) Please feel free to ask questions and the account will answer them the best way possible can without endangering the trade. If you have any info regarding call selling, be sure to comment or send an email.
In doing research for the next trade, the account showed the following results for the Feb options:
1) Eastman Kodak currently has a price of about $4.60 today. The Feb $5.00 option is currently bidding for $0.20.
2)JA Solar currently has a price of about $4.76 today. The Feb option is currently bidding for $0.35
3) TGB is currently trading at about $4.75 today. The Feb $5.00 is currently bidding at $0.15
The Account does not have a position in any of these stocks and has not traded these stocks in the past.
- This information is not to be used as a recommendation to buy or sell. It is simply information (and sometimes opinions) given for the reader of this blog. Before investing, please consult a financial professional. This blog takes no responsibility for any losses or gains occurred from trades that use its material.
- The account does not fully divulge all information on open trades. This is for protection of the trade. When the trade on a particular stock ends, the account will give out the rest of the details (stock name, price purchased, call purchased, news on company/ETF, chart info, etc.) Please feel free to ask questions and the account will answer them the best way possible can without endangering the trade. If you have any info regarding call selling, be sure to comment or send an email.
Tuesday, January 26, 2010
8 weeks to go on current trade
There are eight weeks to go on the current trade. The stock has fallen to the price that the account bought the stock. The price of the call has dropped by over 50% since the account sold it. The stock will have to rise 15% to reach the March strike price.
Using our technical analysis tools from Yahoo Finance and Optionsxpress, the stock is showing to be in a trading range that is above the account's base price and stop loss sell price for the stock.
The stockholders of the company did vote to allow the company to expand its total number of common shares by 65%. This was done to help give the company the opportunity to product partner with larger companies in its industry. The company is currently testing products that will have results published in the next six months (according to the company.)
- Opinions are given on this blog. Before investing, please consult a financial professional. This blog takes no responsibility for any losses occurred from trades that use its material as a basis for the trade.
- The account does not fully divulge all information on companies that have open trades. This is to protect current trade. When the trade on a particular stock ends, the account will give out the rest of the details (stock name, price purchased, call purchased, news on company/ETF, chart info, etc.) Please feel free to ask questions and the account will answer them the best way possible can without endangering the trade. If you have any info regarding call selling, be sure to comment or send an email.
Using our technical analysis tools from Yahoo Finance and Optionsxpress, the stock is showing to be in a trading range that is above the account's base price and stop loss sell price for the stock.
The stockholders of the company did vote to allow the company to expand its total number of common shares by 65%. This was done to help give the company the opportunity to product partner with larger companies in its industry. The company is currently testing products that will have results published in the next six months (according to the company.)
- Opinions are given on this blog. Before investing, please consult a financial professional. This blog takes no responsibility for any losses occurred from trades that use its material as a basis for the trade.
- The account does not fully divulge all information on companies that have open trades. This is to protect current trade. When the trade on a particular stock ends, the account will give out the rest of the details (stock name, price purchased, call purchased, news on company/ETF, chart info, etc.) Please feel free to ask questions and the account will answer them the best way possible can without endangering the trade. If you have any info regarding call selling, be sure to comment or send an email.
Thursday, January 21, 2010
Feb 10 trade opportunity
Hey everyone
In doing research for the next trade, the account has found a stock Immunomedics (IMMU,) that currently has a very high time value placed on its calls. The Feb 5.00 call is being bid at $0.35.
Since the stock is only at $4.50 range, this provides a decent opportunity for call sellers to pick up some call revenue with the opportunity of picking up trading profits should the stock push past $5.00.
The positive move on the stock seems to be made because of good news (go to yahoo.com) related a blood test for cancer that they have been running.
The call selling account does not have an active trade on this company.
- Opinions are given on this blog. Before investing, please consult a financial professional. This blog takes no responsibility for any losses occurred from trades that use its material as a basis for the trade.
- The account does not fully divulge all information on companies that have open trades. This is to protect current trade. When the trade on a particular stock ends, the account will give out the rest of the details (stock name, price purchased, call purchased, news on company/ETF, chart info, etc.) Please feel free to ask questions and the account will answer them the best way possible can without endangering the trade. If you have any info regarding call selling, be sure to comment or send an email.
In doing research for the next trade, the account has found a stock Immunomedics (IMMU,) that currently has a very high time value placed on its calls. The Feb 5.00 call is being bid at $0.35.
Since the stock is only at $4.50 range, this provides a decent opportunity for call sellers to pick up some call revenue with the opportunity of picking up trading profits should the stock push past $5.00.
The positive move on the stock seems to be made because of good news (go to yahoo.com) related a blood test for cancer that they have been running.
The call selling account does not have an active trade on this company.
- Opinions are given on this blog. Before investing, please consult a financial professional. This blog takes no responsibility for any losses occurred from trades that use its material as a basis for the trade.
- The account does not fully divulge all information on companies that have open trades. This is to protect current trade. When the trade on a particular stock ends, the account will give out the rest of the details (stock name, price purchased, call purchased, news on company/ETF, chart info, etc.) Please feel free to ask questions and the account will answer them the best way possible can without endangering the trade. If you have any info regarding call selling, be sure to comment or send an email.
Tuesday, January 19, 2010
new capital
New capital has been invested into the the trading account. Projections show that the account will be able to make higher revenue generating trades as capital increases.
Fourth trade finished
The account just finished with the fourth trade with positive results. The stock ended up closing on Friday below the strike price. Therefor, the option that was sold expired worthless. The option revenue was 6.7% of the stock purchase price.
The stock was also up 6.7% from where it was originally purchased. It is strange that both numbers ended up being the same amount percentage wise.
The fact that the stock is closer to the strike price has helped the time value increase in the next trade.
The stock was also up 6.7% from where it was originally purchased. It is strange that both numbers ended up being the same amount percentage wise.
The fact that the stock is closer to the strike price has helped the time value increase in the next trade.
Subscribe to:
Posts (Atom)
